Thalassemia (British English: thalassaemia), also called Mediterranean anemia, is a form of inherited autosomal recessive blood disorder characterized by abnormal formation of hemoglobin.[1] The abnormal hemoglobin formed results in improper oxygen transport and destruction of red blood cells.[1] Thalassemia is caused by variant or missing genes that affect how the body makeshemoglobin, the protein in red blood cells that carries oxygen. People with thalassemia make less hemoglobin and have fewer circulating red blood cells than normal, which results in mild or severe microcytic anemia.
Thalassemia can cause complications, including iron overload, bone deformities, and cardiovascular illness. However, this same inherited disease of red blood cells may confer a degree of protection against malaria (specifically, malaria caused by the protozoan parasite Plasmodium falciparum), which is or was prevalent in the regions where the trait is common. This selective survival advantage of carriers (known as heterozygous advantage) may be responsible for perpetuating the mutation in populations. In that respect, the various thalassemias resemble another genetic disorder affecting hemoglobin, sickle-cell disease.[2][3]
Thalassemia resulted in 25,000 deaths in 2013 down from 36,000 deaths in 1990.[4]
بنیاد پیشگیری از معلولیت های مادرزادی و ژنتیک خراسان رضوی به همت خیرین و مساعدت سازمان بهزیستی در تیر ماه سال 1388، با هدف کاهش معلولیت در جامعه در شهر مقدس مشهد تاسیس گردید. خیرین بنیاد در عملی کم سابقه درسطح کشور پس از پژوهشها و تحقیقات به عمل آمده جهت سرمایه گذاری در امور خیر مانـــدگار به این نـــتیجه رسیدند کـه جــهت پیــــشگیری از مــــعلولیتهای مــــادرزادی بنیاد یاد شده را تاسیس نمایند.